Prediction of oncologic outcome using systemic neutrophil-to-lymphocyte ratio in stage II and III colon cancer. Park Y, Lee K, Lee J, Oh S, et al. Ann Oncol 2019;30 Suppl 4:iv5.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Park Y, Lee K, Lee J, Oh S, et al. Prediction of oncologic outcome using systemic neutrophil-to-lymphocyte ratio in stage II and III colon cancer. Ann Oncol 2019;30 Suppl 4:iv5.
PMID: 32085186